Target intelligence / Profile preview

Ribosomal protein L15 pseudogene 9 (RPL15P9)

Target
RPL15P9
Molecular classification
Pseudogene, Processed pseudogene, Ribosomal protein pseudogene
01

Overview

Ribosomal protein L15 pseudogene 9 (RPL15P9) is a non-coding processed pseudogene resulting from the reverse transcription and integration of mRNA from the functional ribosomal protein L15 gene (RPL15)[2][4]. Pseudogenes like RPL15P9 contain sequences highly similar to their parent gene but generally lack the ability to produce functional protein due to mutations or lack of regulatory elements needed for expression[4][5]. There are thousands of ribosomal protein pseudogenes distributed throughout the human genome, many arising through retrotransposition events[4]. RPL15P9 does not code for a functional ribosomal protein and does not act as a therapeutic target or disease marker. Some ribosomal pseudogenes, if transcribed, may have minor regulatory roles, but no such role is established for RPL15P9[2]. In summary: RPL15P9 is a canonical pseudogene, nonfunctional in terms of protein coding and not considered a drug target or relevant disease marker. It is one of many ribosomal protein gene-derived pseudogenes present within the genome as a result of evolutionary genomic rearrangements[4][5][9].

Other names
RPL15P10RPL15_3_755ribosomal protein L15 pseudogene 10RPL15P9
02

Mechanism of action

None (no mechanism of action as a drug target; pseudogenes are nonfunctional remnants of genes)

03

Biological functions

None (does not encode a functional protein; at most, if expressed, might provide subtle regulatory RNA effects)
04

Disease associations

Other (no known direct disease association; functional ribosomal protein genes, in contrast, may have roles in cancer or other conditions, but not established for this pseudogene)
05

Safety considerations

None relevant (not therapeutically targeted)
06

Interacting drugs

None (no drugs interact with this pseudogene; not a therapeutic target)
07

Biomarkers

None (not known or used as a biomarker)

Beyond the preview

Go deeper on Ribosomal protein L15 pseudogene 9 (RPL15P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L15 pseudogene 9 (RPL15P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call